Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lexaria Bioscience Corp.LEXX · Entity 7641 | Director | March 17, 2026 | March 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lexaria Bioscience Corp.
Report date March 17, 2026 · Filed March 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| common sharesSEC Table I · non-derivative | Direct | 273,543 |
Reported balance
After 2026-03-17 transaction · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · 2026-03-17 · Gift · Disposed 100,000 · Balance 273,543 F1: The 100,000 shares were gifted back to Lexaria Bioscience Corp. and returned to treasury. |
| common sharesSEC Table I · non-derivative | Direct | 373,543 |
Reported balance
Holding disclosure · report date 2026-03-17 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 373,543 |
| common sharesSEC Table I · non-derivative | IndirectPrivate Holding Company | 281,912 |
Reported balance
Holding disclosure · report date 2026-03-17 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 281,912 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $3.00 · Expires 2026-04-26 | Direct | 26,000 |
Reported balance
Holding disclosure · report date 2026-03-17 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 26,000 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $3.00 · Expires 2026-06-08 | Direct | 49,334 |
Reported balance
Holding disclosure · report date 2026-03-17 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 49,334 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $3.00 · Expires 2026-09-01 | Direct | 64,334 |
Reported balance
Holding disclosure · report date 2026-03-17 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 64,334 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.91 · Expires 2027-08-29 | Direct | 94,334 |
Reported balance
Holding disclosure · report date 2026-03-17 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 94,334 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.15 · Expires 2028-10-26 | Direct | 124,334 |
Reported balance
Holding disclosure · report date 2026-03-17 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 124,334 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.36 · Expires 2029-04-26 | Direct | 173,834 |
Reported balance
Holding disclosure · report date 2026-03-17 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 173,834 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.04 · Expires 2030-05-15 | Direct | 184,834 |
Reported balance
Holding disclosure · report date 2026-03-17 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 184,834 |
Filing footnotes · ownership attribution and instrument terms
F1: The 100,000 shares were gifted back to Lexaria Bioscience Corp. and returned to treasury.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 17, 2026 Filed Mar 18, 2026 15:37 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | Giftcommon shares | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001103780-26-000001 · primary_doc.xml · nonDerivative · entry 3 BUNKA CHRISTOPHER · CIK 0001103780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,543 F1 · shares: The 100,000 shares were gifted back to Lexaria Bioscience Corp. and returned to treasury. Read SEC document |
| July 30, 2025 Filed Jul 30, 2025 21:12 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | Purchasecommon shares | 11,900 | $0.91 | $10,865.89 |
DisclosureSEC source: 0001348362-25-000016 · primary_doc.xml · nonDerivative · entry 4 BUNKA CHRISTOPHER · CIK 0001103780 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Private Holding Company Disclosed balance after: 281,912 Read SEC document |
| July 29, 2025 Filed Jul 30, 2025 21:12 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | Purchasecommon shares | 15,600 | $0.92 | $14,375.40 |
DisclosureSEC source: 0001348362-25-000016 · primary_doc.xml · nonDerivative · entry 3 BUNKA CHRISTOPHER · CIK 0001103780 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Private Holding Company Disclosed balance after: 270,012 Read SEC document |
| May 15, 2025 Filed May 16, 2025 21:39 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | GrantStock Options · Derivative | 11,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001348362-25-000010 · primary_doc.xml · derivative · entry 9 BUNKA CHRISTOPHER · CIK 0001103780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,834 Underlying: Common Shares · 11,000 shares Expires 2030-05-15 Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 16:52 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | GrantRestricted Stock Award | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001348362-25-000001 · primary_doc.xml · nonDerivative · entry 3 BUNKA CHRISTOPHER · CIK 0001103780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373,543 F2 · price: The closing price on the Issuer's shares on the date of grant was $2.24. F1 · balance_after: Beneficial ownership reflects the aggregate securities held directly. Read SEC document |
| April 26, 2024 Filed May 10, 2024 20:44 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | GrantStock Options · Derivative | 49,500 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001855763-24-000005 · primary_doc.xml · derivative · entry 9 BUNKA CHRISTOPHER · CIK 0001103780 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,501 Underlying: Common Shares · 49,500 shares Expires 2029-04-26 Read SEC document |
| October 26, 2023 Filed Oct 30, 2023 16:30 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | GrantStock Options · Derivative | 30,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001855763-23-000007 · primary_doc.xml · derivative · entry 8 BUNKA CHRISTOPHER · CIK 0001103780 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,001 Underlying: Common Shares · 30,000 shares Expires 2028-10-26 Read SEC document |
| October 13, 2022 Filed Oct 13, 2022 21:00 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | Grantcommon shares | 16,600 | $2.10 | $34,860.00 |
DisclosureSEC source: 0001855763-22-000014 · primary_doc.xml · nonDerivative · entry 4 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Private Holding Company Disclosed balance after: 254,412 Read SEC document |
| October 13, 2022 Filed Oct 18, 2022 22:20 UTC Amendment | Lexaria Bioscience Corp. LEXX · Entity 7641 | Purchasecommon shares | 16,600 | $2.10 | $34,860.00 |
DisclosureSEC source: 0001855763-22-000019 · primary_doc.xml · nonDerivative · entry 4 BUNKA CHRISTOPHER · CIK 0001103780 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Private Holding Company Disclosed balance after: 254,412 F1 · kind: This Form 4/A is being filed to correct the transaction code for the open market purchase of common shares made by Mr. Bunka as previously notated as a grant or award in the Form 4 originally filed on 10/13/2022. Read SEC document |
| October 12, 2022 Filed Oct 13, 2022 21:00 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | Grantcommon shares | 21,900 | $1.99 | $43,537.20 |
DisclosureSEC source: 0001855763-22-000014 · primary_doc.xml · nonDerivative · entry 3 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Private Holding Company Disclosed balance after: 237,812 Read SEC document |
| October 12, 2022 Filed Oct 18, 2022 22:20 UTC Amendment | Lexaria Bioscience Corp. LEXX · Entity 7641 | Purchasecommon shares | 21,900 | $1.99 | $43,537.20 |
DisclosureSEC source: 0001855763-22-000019 · primary_doc.xml · nonDerivative · entry 3 BUNKA CHRISTOPHER · CIK 0001103780 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Private Holding Company Disclosed balance after: 237,812 F1 · kind: This Form 4/A is being filed to correct the transaction code for the open market purchase of common shares made by Mr. Bunka as previously notated as a grant or award in the Form 4 originally filed on 10/13/2022. Read SEC document |
| August 29, 2022 Filed Aug 29, 2022 21:18 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | GrantStock Options · Derivative | 30,000 | $0.00 Strike: $2.91 | $0.00 |
DisclosureSEC source: 0001855763-22-000008 · primary_doc.xml · derivative · entry 7 BUNKA CHRISTOPHER · CIK 0001103780 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,001 Underlying: Common Shares · 30,000 shares Expires 2027-08-29 Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 17:58 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | GrantStock Options · Derivative | 15,000 | $0.00 Strike: $6.23 | $0.00 |
DisclosureSEC source: 0001855763-21-000027 · primary_doc.xml · derivative · entry 6 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,001 Underlying: Common Shares · 15,000 shares Expires 2026-09-01 Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 16:57 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | GrantStock Options · Derivative | 23,334 | $0.00 Strike: $7.08 | $0.00 |
DisclosureSEC source: 0001855763-21-000016 · primary_doc.xml · derivative · entry 5 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,001 Underlying: Common Shares · 23,334 shares Expires 2026-06-08 Read SEC document |
| May 07, 2021 Filed Jun 9, 2021 16:48 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | OtherStock Options · Derivative | 23,334 | $0.00 Strike: $10.20 | $0.00 |
DisclosureSEC source: 0001855763-21-000015 · primary_doc.xml · derivative · entry 6 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,667 Underlying: Common Shares · 23,334 shares Expires 2025-04-23 F1 · kind: Cancelled Options Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 21:13 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | GrantStock Options · Derivative | 26,000 | $0.00 Strike: $5.83 | $0.00 |
DisclosureSEC source: 0001855763-21-000006 · primary_doc.xml · derivative · entry 5 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,001 Underlying: Common Shares · 26,000 shares Expires 2026-04-26 Read SEC document |
| November 10, 2020 Filed Nov 10, 2020 20:48 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Purchasecommon shares | 25,500 | $0.19 | $4,799.10 |
DisclosureSEC source: 0001103780-20-000004 · primary_doc.xml · nonDerivative · entry 12 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private Holding Company Disclosed balance after: 6,477,344 Read SEC document |
| November 10, 2020 Filed Nov 10, 2020 20:48 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Purchasecommon shares | 6,000 | $0.20 | $1,199.40 |
DisclosureSEC source: 0001103780-20-000004 · primary_doc.xml · nonDerivative · entry 11 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private Holding Company Disclosed balance after: 6,451,844 Read SEC document |
| November 10, 2020 Filed Nov 10, 2020 20:48 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Purchasecommon shares | 10,000 | $0.20 | $1,950.00 |
DisclosureSEC source: 0001103780-20-000004 · primary_doc.xml · nonDerivative · entry 10 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private Holding Company Disclosed balance after: 6,445,844 Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 20:48 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Purchasecommon shares | 22,000 | $0.20 | $4,391.20 |
DisclosureSEC source: 0001103780-20-000004 · primary_doc.xml · nonDerivative · entry 9 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private Holding Company Disclosed balance after: 6,435,844 Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 20:48 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Purchasecommon shares | 6,500 | $0.20 | $1,306.50 |
DisclosureSEC source: 0001103780-20-000004 · primary_doc.xml · nonDerivative · entry 8 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private Holding Company Disclosed balance after: 6,413,844 Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 20:48 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Purchasecommon shares | 8,000 | $0.20 | $1,600.00 |
DisclosureSEC source: 0001103780-20-000004 · primary_doc.xml · nonDerivative · entry 7 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private Holding Company Disclosed balance after: 6,407,344 Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 20:48 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Purchasecommon shares | 10,000 | $0.21 | $2,129.00 |
DisclosureSEC source: 0001103780-20-000004 · primary_doc.xml · nonDerivative · entry 6 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private Holding Company Disclosed balance after: 6,399,344 Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 20:48 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Purchasecommon shares | 10,000 | $0.20 | $2,025.00 |
DisclosureSEC source: 0001103780-20-000004 · primary_doc.xml · nonDerivative · entry 5 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private Holding Company Disclosed balance after: 6,389,344 Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 20:48 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Purchasecommon shares | 37,500 | $0.22 | $8,062.50 |
DisclosureSEC source: 0001103780-20-000004 · primary_doc.xml · nonDerivative · entry 4 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private Holding Company Disclosed balance after: 6,379,344 Read SEC document |
| November 06, 2020 Filed Nov 10, 2020 20:48 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Purchasecommon shares | 60,000 | $0.21 | $12,306.00 |
DisclosureSEC source: 0001103780-20-000004 · primary_doc.xml · nonDerivative · entry 3 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private Holding Company Disclosed balance after: 6,341,844 Read SEC document |
| May 06, 2020 Filed May 8, 2020 23:05 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Grantcommon shares | 200,000 | $0.23 | $46,000.00 |
DisclosureSEC source: 0001103780-20-000002 · primary_doc.xml · nonDerivative · entry 3 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private Holding Company Disclosed balance after: 6,281,844 Read SEC document |
| May 06, 2020 Filed Jun 4, 2020 21:16 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantWarrants · Derivative | 200,000 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001103780-20-000003 · primary_doc.xml · derivative · entry 4 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private Holding Company Disclosed balance after: 200,000 Underlying: Common Shares · 200,000 shares Expires 2025-05-06 Read SEC document |
| April 23, 2020 Filed Apr 23, 2020 17:30 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Grantstock options · Derivative | 700,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001103780-20-000001 · primary_doc.xml · derivative · entry 3 BUNKA CHRISTOPHER · CIK 0001103780 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700,000 Underlying: common shares · 700,000 shares Expires 2025-04-23 Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 18:34 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Otherstock options · Derivative | 700,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001348362-20-000005 · primary_doc.xml · derivative · entry 4 BUNKA CHRISTOPHER · CIK 0001103780 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 700,000 shares Expires 2023-05-31 F1 · kind: Cancellation of Options Read SEC document |
| April 05, 2019 Filed Apr 8, 2019 21:31 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | OtherStock Options · Derivative | 550,000 | $0.10 Strike: $0.10 | $55,000.00 |
DisclosureSEC source: 0001348362-19-000002 · primary_doc.xml · derivative · entry 5 BUNKA CHRISTOPHER · CIK 0001103780 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700,000 Underlying: Common Shares · 550,000 shares Expires 2019-12-23 F1 · kind: Cancellation of Options Read SEC document |
| August 31, 2018 Filed Sep 4, 2018 20:56 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantCommon Shares | 32,500 | $2.07 | $67,275.00 |
DisclosureSEC source: 0001103780-18-000004 · primary_doc.xml · nonDerivative · entry 3 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,126,304 Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 19:57 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GiftCommon Shares | 500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-18-003472 · form4.xml · nonDerivative · entry 3 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,093,804 F1 · shares: Consisted of a Charitable Donation to a registered non-profit organization F1 · price: Consisted of a Charitable Donation to a registered non-profit organization Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 19:31 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantCommon Shares | 81,250 | $1.24 | $100,750.00 |
DisclosureSEC source: 0001103780-18-000003 · primary_doc.xml · nonDerivative · entry 3 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,593,804 Read SEC document |
| June 18, 2018 Filed Jun 19, 2018 19:19 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Exercise / conversionWarrants · Derivative | 450,000 | $0.14 Strike: $0.14 | $63,000.00 |
DisclosureSEC source: 0001103780-18-000002 · primary_doc.xml · derivative · entry 10 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private holding company Disclosed balance after: 0 Underlying: Common Shares · 450,000 shares Expires 2018-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2018 Filed Jun 19, 2018 19:19 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Exercise / conversionStock Options · Derivative | 247,500 | $0.09 Strike: $0.09 | $22,275.00 |
DisclosureSEC source: 0001103780-18-000002 · primary_doc.xml · derivative · entry 8 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Shares · 247,500 shares Expires 2018-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2018 Filed Jun 19, 2018 19:19 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Exercise / conversionCommon Shares | 247,500 | $0.09 | $22,275.00 |
DisclosureSEC source: 0001103780-18-000002 · primary_doc.xml · nonDerivative · entry 4 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,512,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2018 Filed Jun 19, 2018 19:19 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Exercise / conversionCommon Shares | 450,000 | $0.14 | $63,000.00 |
DisclosureSEC source: 0001103780-18-000002 · primary_doc.xml · nonDerivative · entry 3 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private holding company Disclosed balance after: 6,081,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2018 Filed May 31, 2018 18:42 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantStock Options · Derivative | 700,000 | $1.53 Strike: $1.53 | $1,071,000.00 |
DisclosureSEC source: 0001103780-18-000001 · primary_doc.xml · derivative · entry 6 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,497,500 Underlying: Common Shares · 700,000 shares Expires 2023-05-31 Read SEC document |
| December 01, 2017 Filed Dec 1, 2017 20:53 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantCommon Shares | 29,475 | $0.82 | $24,169.50 |
DisclosureSEC source: 0001103780-17-000002 · primary_doc.xml · nonDerivative · entry 3 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,265,054 Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 20:41 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantCommon Shares | 210,000 | $0.30 | $61,950.00 |
DisclosureSEC source: 0001103780-17-000001 · primary_doc.xml · nonDerivative · entry 3 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private holding company Disclosed balance after: 5,631,844 Read SEC document |
| October 07, 2016 Filed Oct 11, 2016 19:01 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | PurchaseCommon Shares | 5,000 | $0.12 | $600.00 |
DisclosureSEC source: 0001103780-16-000095 · primary_doc.xml · nonDerivative · entry 5 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,235,579 Read SEC document |
| October 07, 2016 Filed Oct 11, 2016 19:01 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | PurchaseCommon Shares | 5,000 | $0.13 | $625.00 |
DisclosureSEC source: 0001103780-16-000095 · primary_doc.xml · nonDerivative · entry 4 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,230,579 Read SEC document |
| October 07, 2016 Filed Oct 11, 2016 19:01 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | PurchaseCommon Shares | 10,000 | $0.13 | $1,290.00 |
DisclosureSEC source: 0001103780-16-000095 · primary_doc.xml · nonDerivative · entry 3 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,225,579 Read SEC document |
| October 05, 2016 Filed Oct 6, 2016 22:38 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | PurchaseCommon Shares | 2,500 | $0.15 | $362.50 |
DisclosureSEC source: 0001103780-16-000094 · primary_doc.xml · nonDerivative · entry 3 BUNKA CHRISTOPHER · CIK 0001103780 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,215,579 F1 · price: (1) Canadian Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.